CD4 and HIV infectious disease: The drug fingolimod itself, as used in current neurological practice, is very problematic for the treatment of HIV infection or HAND since fingolimod’s actions on lymphocyte trafficking lead to a dramatic reduction in the number of circulating CD4-positive lymphocytes.